Latest Regulatory Approvals News

MedAdvisor Limited has successfully closed its Share Purchase Plan, raising $2.668 million-exceeding its $2 million target-and plans an upcoming shareholder meeting to approve director share issuances.

Amplia Therapeutics reports a significant milestone in its ACCENT trial, with 15 confirmed partial responses indicating that narmafotinib combined with chemotherapy outperforms chemotherapy alone in advanced pancreatic cancer.

Euro Manganese Inc. reported a net loss of CAD 9.174 million for the half-year ending March 31, 2025, while making significant progress on its Chvaletice Manganese Project, including securing key permits and strategic status under EU and Czech frameworks. The company’s development hinges on completing a crucial private placement and share purchase plan to sustain operations.

Euro Manganese advances its Chvaletice manganese project with key regulatory approvals, leadership appointments, and a $9.8 million capital raise, while reporting a narrowed Q3 net loss.

Bass Oil Limited has announced a $3.1 million rights issue to fund key projects including recommissioning a gas facility in Australia and drilling an oil well in Indonesia, aiming to significantly increase production and cash flow.

Exxaro Resources has agreed to acquire a near 20% stake in Jupiter Mines and a controlling interest in the Tshipi Manganese Mine, reshaping ownership and operational dynamics in the Kalahari Manganese Field.

Carbine Resources has been granted a long-term mining lease for its Muchea Silica Sand Project, marking a significant step forward while awaiting further regulatory approvals.

Lake Resources has increased its Measured and Indicated lithium resource at the Kachi Project in Argentina to 8.2 million tonnes LCE, revealing higher-grade lithium zones and enhanced recovery technology. This update strengthens the project's economic outlook amid ongoing feasibility and environmental assessments.

EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.

Core Lithium's Restart Study for the Finniss Lithium Operation confirms a 20-year underground mine life with significant cost reductions and enhanced production capacity.

Tamboran Resources has finalized a US$15 million sale of 100,000 acres to Daly Waters Energy, retaining a dominant 1.9 million-acre position in the Beetaloo Basin and setting the stage for its Phase 2 gas development targeting Australia's East Coast market.

Tamboran Resources has raised US$55.4 million through a private placement to fund critical drilling activities in the Beetaloo Basin, aiming for first gas production by mid-2026.